Skip to content

Biomarker Expression, predicts risk of re-AMputation, impaired woundhealing and secundairy systemic cardiovascualr events, in patients with endstage peripheral atherosclerotic disease undergoing leg amputation due to advanced atherosclerotic disease. The "BEAM" study.

Biomarker Expression, predicts risk of re-AMputation, impaired woundhealing and secundairy systemic cardiovascualr events, in patients with endstage peripheral atherosclerotic disease undergoing leg amputation due to advanced atherosclerotic disease. The "BEAM" study. - Biomarkers and risk of re-AMputation and systemic cardiovascular events

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38319
Enrollment
200
Registered
2012-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis Critical Limb Ishemia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients between 18-99 years old with critical limb ischemia and without medical treatment options, revascularization possibilities or exercise treatment.

Exclusion criteria

Exclusion criteria: Younger than 18 years old, HIV positive patients

Design outcomes

Primary

MeasureTime frame
The study parameters have not been defined yet, a number of different proteins will be investigated as well as histology including vessel density. These parameters will be related to patient and follow-up data. Follow-up parameters include: 1: re-amputation withing 3 years following primary amputation 2: woundinfection 3: duration of correct woundhealing ( days following surgery, within 6 weeks after surgery)

Secondary

MeasureTime frame
A: Acute other manifestations of atherosclerosis (myocardial infarction, cerbrsl infarction and peripheral intervention)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)